SEATTLE, July 30, Jul 30, 2021 (GLOBE NEWSWIRE via COMTEX) --
SEATTLE, July 30, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global peripherally inserted central catheters market is estimated to be valued at US$857.7million in 2021 and is expected to exhibit a CAGR of 6.9% during the forecast period (2021-2028).
The increasing number of drug approvals by Canada regulatory bodies is expected to drive the growth of global peripherally inserted central catheters market. For instance, in August 2016, AngioDynamics Inc., a provider of medical devices, received approval from the Health Canada for its Celerity PICC Tip Confirmation System developed for the positioning of Peripherally Inserted Central Catheters (PICCs) in adult patients.
Increasing number of product launches is expected to propel the market growth over the forecast period. For instance, in October 2018, the U.S. Food & Drug Administration (FDA) approved Crescent Jugular Dual Lumen Catheter which is designed for extracorporeal membrane oxygenation and manufactured by MC3 Cardiopulmonary, a U.S.-based medical device firm.
The increasing number inorganic growth strategies such as acquisition by key players will drive the growth of market over the forecast period. For instance, in July 2018, Becton, Dickinson and Company acquired TVA Medical, Inc., a developer of minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis.
Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4048
The increasing number of inorganic growth strategies such as partnership is expected to drive the growth of global peripherally inserted central catheters market over the forecast period. For instance, in March 2017, Bluegrass Vascular Technologies entered into a strategic partnership with Merit Medical Systems, a manufacturer and marketer of proprietary disposable devices, for the distribution of Surfacer Inside-Out Access Catheter System in the European region.
Key Market Takeaways:
North America peripherally inserted central catheters market is expected to hold the largest share in global peripherally inserted central catheters market by exhibiting a CAGR of 7.1% during the forecast period (2021-2028). North America peripherally inserted central catheters market is expected to boost during the forecast period owing to rising prevalence of chronic diseases such as end-stage kidney disease (ESKD) and cancer in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), around 125,000 people started the treatment for end-stage kidney disease (ESKD) and over 726,000 people were either on dialysis or living with a kidney transplant in the U.S., in 2016.
Increasing number of of blood transfusion are performed globally which is anticipated to drive the growth of global peripherally inserted central catheters market over the forecast period. For instance, According to the National Health Service (NHS), around 2.5 million units of blood are transfused every year in the U.K.
Key players operating in the global peripherally inserted central catheters market include AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook Medical Inc., ICU Medical, Inc., Medical Components, Inc., Access Vascular., and Vygon (UK) Ltd.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4048
Global Peripherally Inserted Central Catheters Market, By Product Type:
Global Peripherally Inserted Central Catheters Market, By End user:
Global Peripherally Inserted Central Catheters Market, By Region:
Related Market Intelligence Reports:
Polycythemia Vera Therapeutics Market, by Disease Type (Primary Polycythemia Vera and Secondary Polycythemia Vera), by Drug Class (Antimetabolite, Kinase Inhibitors, Alpha Interferon, Selective Serotonin Reuptake Inhibitors, and Others), by Route of Administration (Oral, Intravenous, Intramuscular, and Subcutaneous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
Severe Acute Respiratory Syndrome (SARS) Treatment Market, By Drug Class (Antibiotics, Antiviral, Corticosteroids, Monoclonal antibodies, and Others), By Indication (SARS-CoV and SARS-CoV-2) , By Route of Administration (Oral and Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region/Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021-2028
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
Mr. Shah Senior Client Partner - Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: email@example.com Website: https://www.coherentmarketinsights.com
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.
(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.